Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call Transcript January 2, 2025
Lifecore Biomedical, Inc. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.27.
Operator: Good afternoon, and thank you for joining LifeCor’s financial 2025 second quarter earnings call. During the call, all participants will be in a listen-only mode. Now, I would like to turn the call over to Stephanie Diaz, Manager of Investor Relations for LifeCor. Please go ahead.
Stephanie...
